CRBP Valuation
Corbus Pharmaceuticals Holdings Inc
$
7.620
- Overview
- Forecast
- Valuation
CRBP Relative Valuation
CRBP's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CRBP is overvalued; if below, it's undervalued.
Historical Valuation
No Data
Competitors Valuation Multiple
The average P/S ratio for CRBP's competitors is 14.14, providing a benchmark for relative valuation. Corbus Pharmaceuticals Holdings Inc Corp (CRBP) exhibits a P/S ratio of 61.76, which is 336.77% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
AGNCL
AGNC Investment Corp. Depositary Shares Each Representing a 1/1,000th Interest in a Share of 7.75% S
25.330
USD
0.00%
BMEA
Biomea Fusion Inc
1.455
USD
-4.28%
EPSN
Epsilon Energy Ltd
6.970
USD
0.00%
ZJYL
Jin Medical International Ltd
0.790
USD
-0.88%
CBFV
CB Financial Services Inc
29.435
USD
-0.97%
CSTE
Caesarstone Ltd
1.990
USD
-3.86%
CXDO
Crexendo Inc
5.868
USD
+0.48%
SHIP
Seanergy Maritime Holdings Corp
6.060
USD
-1.30%
FATE
Fate Therapeutics Inc
1.175
USD
+9.81%
PDEX
Pro-Dex Inc
43.580
USD
+1.07%
FAQ
Is Corbus Pharmaceuticals Holdings Inc (CRBP) currently overvalued or undervalued?
Corbus Pharmaceuticals Holdings Inc (CRBP) is now in the Fair zone, suggesting that its current forward PS ratio of 61.76 is considered Fairly compared with the five-year average of 70.04. The fair price of Corbus Pharmaceuticals Holdings Inc (CRBP) is between to according to relative valuation methord.
What is Corbus Pharmaceuticals Holdings Inc (CRBP) fair value?
How does CRBP's valuation metrics compare to the industry average?
What is the current P/B ratio for Corbus Pharmaceuticals Holdings Inc (CRBP) as of May 19 2025?
What is the current FCF Yield for Corbus Pharmaceuticals Holdings Inc (CRBP) as of May 19 2025?
What is the current Forward P/E ratio for Corbus Pharmaceuticals Holdings Inc (CRBP) as of May 19 2025?